← Eichor
Condition: Non Cystic Fibrosis Bronchiectasis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Non Cystic Fibrosis Bronchiectasis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

BASE: Bronchiectasis Severity and Exacerbation Risk Study
Phase N/A · 1 location(s) · Assiut University · NCT07599839A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled R
Phase 1 · 1 location(s) · Revagenix, Inc. · NCT07709494Breathing Training and Exercise Capacity in Non-CFB
NA · 1 location(s) · Mayo Clinic · NCT05860803Regional Phenotyping of CF and Non-CF Bronchiectasis
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04793867A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Phase 2 · 51 location(s) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahw · NCT06559150A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Phase 3 · 2 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT06660992A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age Wi
Phase 2 · 4 location(s) · Sanofi · NCT07547436Study of Bronchiectasis and Associated Cardiovascular Comorbidities
Phase N/A · 1 location(s) · Assiut University · NCT05783869A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Phase 3 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT07616375Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT06775340Hypertonic Saline in NCFB
Phase 4 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06242795Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT06985225A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
Phase N/A · 38 location(s) · AstraZeneca · NCT07245407Bronchiectasis Phenotype Identification Model
Phase N/A · 1 location(s) · Assiut University · NCT07599969A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04538859Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NC
Phase 2 · 13 location(s) · CSL Behring · NCT07048262Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
NA · 57 location(s) · Physio-Assist · NCT06487273A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Phase 1 · 7 location(s) · Genentech, Inc. · NCT06603246Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchie
Phase N/A · 1 location(s) · Papworth Hospital NHS Foundation Trust · NCT07289100A Clinical Study of RSS0343 in Healthy Subjects
Phase 1 · 1 location(s) · Reistone Biopharma Company Limited · NCT07289464Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis
Phase 2 · 18 location(s) · Centre Hospitalier Intercommunal Creteil · NCT06368804
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.